|This Slide: #76 of 83|
Slide #76. PerkinElmer — Shanghai Haoyuan Biotech Co., Ltd.,
Shanghai Haoyuan Biotech Co., Ltd.,
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, announced today that it has completed the acquisition of Shanghai Haoyuan Biotech Co., Ltd., a China-based infectious disease diagnostics company. The acquisition extends PerkinElmer's capabilities into nucleic acid blood screening and in the growing molecular clinical diagnostics market in China, further strengthening the Company's position as a diagnostics leader in China as well as across the globe.
PerkinElmer provides products, services and solutions for the diagnostics, life sciences and applied markets. Co. ‘s segments are: Discovery and Analytical Solutions and Diagnostics. Co.'s Discovery and Analytical Solutions segment serves: the life sciences, which consist of the life sciences research market and laboratory services market; and applied markets, which consist of environmental, food and industrial markets. Co.'s Diagnostics segment provides instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians and medical research personnel. Co.'s Diagnostics segment is focused on reproductive health, immunodiagnostics, diagnostics and applied genomics.
PerkinElmer SEC Filing Email Alerts Service
Open the PKI Page at The Online Investor »
Free PKI Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Hold (2.50 out of 4)